Archetype Wealth Partners Bristol Myers Squibb CO Transaction History

Archetype Wealth Partners

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $325,832 - $369,430	6,791 New	6,791 $368,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $927,907 - $1.01 Million	-14,988 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$59.34 - $66.74 $3,679 - $4,137	-62 Reduced 0.41%	14,988 $946,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $198,336 - $224,752	-3,435 Reduced 18.58%	15,050 $934,000
Q3 2020 Oct 15, 2020	SELL	$57.43 - $63.64 $51,399 - $56,957	-895 Reduced 4.62%	18,485 $1.11 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $93,194 - $108,953	1,700 Added 9.62%	19,380 $1.14 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $820,352 - $1.19 Million	17,680 New	17,680 $985,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Archetype Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Archetype Wealth Partners with notifications on news.